Additional Resources

Review the current role of PSA biomarkers, strategies for increasing specificity of PSA testing, and expert advise for optimizing risk assessment protocols.

Learn how the Serum HER-2/neu Test can indicate whether metastatic breast cancer is progressing or responding to treatment.